These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 36259470)

  • 41. Clinical and immunologic factors associated with bullous pemphigoid relapse during the first year of treatment: a multicenter, prospective study.
    Fichel F; Barbe C; Joly P; Bedane C; Vabres P; Truchetet F; Aubin F; Michel C; Jegou J; Grange F; Antonicelli F; Bernard P
    JAMA Dermatol; 2014 Jan; 150(1):25-33. PubMed ID: 24226428
    [TBL] [Abstract][Full Text] [Related]  

  • 42. IgE autoantibodies against the intracellular domain of BP180.
    Dresow SK; Sitaru C; Recke A; Oostingh GJ; Zillikens D; Gibbs BF
    Br J Dermatol; 2009 Feb; 160(2):429-32. PubMed ID: 18808416
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pemphigoid with antibodies to laminin γ1, BP180 and BP230, associated with psoriasis vulgaris: successful disease control with cyclosporin.
    Imanishi A; Tateishi C; Imanishi H; Sowa-Osako J; Koga H; Tsuruta D; Hashimoto T
    J Dermatol; 2015 Apr; 42(4):394-7. PubMed ID: 25708520
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Eosinophils, Basophils, and Neutrophils in Bullous Pemphigoid.
    Limberg MM; Weihrauch T; Gray N; Ernst N; Hartmann K; Raap U
    Biomolecules; 2023 Jun; 13(7):. PubMed ID: 37509055
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prospective study in bullous pemphigoid: association of high serum anti-BP180 IgG levels with increased mortality and reduced Karnofsky score.
    Holtsche MM; Goletz S; van Beek N; Zillikens D; Benoit S; Harman K; Walton S; English J; Sticherling M; Chapman A; Levell NJ; Groves R; Williams HC; König IR; Schmidt E;
    Br J Dermatol; 2018 Oct; 179(4):918-924. PubMed ID: 29607480
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid.
    Schmidt E; Obe K; Bröcker EB; Zillikens D
    Arch Dermatol; 2000 Feb; 136(2):174-8. PubMed ID: 10677092
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anti-BP180 and anti-BP230 enzyme-linked immunosorbent assays for diagnosis and disease activity tracking of bullous pemphigoid: A prospective cohort study.
    Chanprapaph K; Ounsakul V; Pruettivorawongse D; Thadanipon K
    Asian Pac J Allergy Immunol; 2021 Dec; 39(4):272-278. PubMed ID: 31175713
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Circulating bullous pemphigoid autoantibodies in the setting of negative direct immunofluorescence findings for bullous pemphigoid: A single-center retrospective review.
    Wang M; Lehman JS; Camilleri MJ; Drage LA; Wieland CN
    J Am Acad Dermatol; 2019 Aug; 81(2):472-479. PubMed ID: 30928465
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [EFFECTIVE TREATMENT FOR BULLOUS PEMPHIGOID WITH OMALIZUMAB].
    Neumark M; Tal Y; Zlotogorski A; Molho-Pessach V
    Harefuah; 2020 Jan; 159(1):29-30. PubMed ID: 31930804
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Bullous pemphigoid].
    Schulze F; Kasperkiewicz M; Zillikens D; Schmidt E
    Hautarzt; 2013 Dec; 64(12):931-43; quiz 944-5. PubMed ID: 24337308
    [TBL] [Abstract][Full Text] [Related]  

  • 51. IgG, IgA and IgE autoantibodies against the ectodomain of BP180 in patients with bullous and cicatricial pemphigoid and linear IgA bullous dermatosis.
    Christophoridis S; Büdinger L; Borradori L; Hunziker T; Merk HF; Hertl M
    Br J Dermatol; 2000 Aug; 143(2):349-55. PubMed ID: 10951144
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Case Report: Combination of Omalizumab and Dupilumab for Recalcitrant Bullous Pemphigoid.
    Seyed Jafari SM; Feldmeyer L; Bossart S; Simon D; Schlapbach C; Borradori L
    Front Immunol; 2020; 11():611549. PubMed ID: 33584689
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid.
    Di Zenzo G; Thoma-Uszynski S; Fontao L; Calabresi V; Hofmann SC; Hellmark T; Sebbag N; Pedicelli C; Sera F; Lacour JP; Wieslander J; Bruckner-Tuderman L; Borradori L; Zambruno G; Hertl M
    Clin Immunol; 2008 Sep; 128(3):415-26. PubMed ID: 18571472
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gliptin-associated bullous pemphigoid shows peculiar features of anti-BP180 and -BP230 humoral response: Results of a multicenter study.
    Salemme A; Fania L; Scarabello A; Caproni M; Marzano AV; Cozzani E; Feliciani C; De Simone C; Papini M; Satta RR; Parodi A; Mariotti F; Lechiancole S; Genovese G; Passarelli F; Festa F; Bellei B; Provini A; Sordi D; Pallotta S; Abeni D; Mazzanti C; Didona B; Di Zenzo G;
    J Am Acad Dermatol; 2022 Jul; 87(1):56-63. PubMed ID: 35240229
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relapse-associated autoantibodies to BP180 in a patient with anti-p200 pemphigoid.
    Kasperkiewicz M; Hoppe U; Zillikens D; Schmidt E
    Clin Exp Dermatol; 2010 Aug; 35(6):614-7. PubMed ID: 19874345
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The significance of preclinical anti-BP180 autoantibodies.
    Mai Y; Izumi K; Mai S; Ujiie H
    Front Immunol; 2022; 13():963401. PubMed ID: 36003369
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of a new ELISA assay for detection of BP230 autoantibodies in bullous pemphigoid.
    Tampoia M; Lattanzi V; Zucano A; Villalta D; Filotico R; Fontana A; Vena GA; Di Serio F
    Ann N Y Acad Sci; 2009 Sep; 1173():15-20. PubMed ID: 19758126
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of a potential effector function for IgE autoantibodies in the organ-specific autoimmune disease bullous pemphigoid.
    Dimson OG; Giudice GJ; Fu CL; Van den Bergh F; Warren SJ; Janson MM; Fairley JA
    J Invest Dermatol; 2003 May; 120(5):784-8. PubMed ID: 12713582
    [TBL] [Abstract][Full Text] [Related]  

  • 59. IgA autoantibodies in the pemphigoids and linear IgA bullous dermatosis.
    Horváth B; Niedermeier A; Podstawa E; Müller R; Hunzelmann N; Kárpáti S; Hertl M
    Exp Dermatol; 2010 Jul; 19(7):648-53. PubMed ID: 20500772
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Unraveling the significance of IgE autoantibodies in organ-specific autoimmunity: lessons learned from bullous pemphigoid.
    Messingham KA; Holahan HM; Fairley JA
    Immunol Res; 2014 Aug; 59(1-3):273-8. PubMed ID: 24845463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.